Found 8 matching trials
A Study of RC18 Administered Subcutaneously to Subjects With Primary IgA(Immunoglobulin A) Nephropathy PHASE2 To evaluate the safety and efficacy of Tai Ai(Recombinant Human B Lymphocyt...
Show More Location
Peking University First Hospital.
Learn More & Join Trial
A Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sjögren's Syndrome PHASE2 The purpose of this study is to initially observe the safety and effectivit...
Show More Location
The First Affiliated Hospital of Bengbu Medical University
Learn More & Join Trial
A Study of TACI(Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor)-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis PHASE2 The purpose of this study is to initially observe the safety and effectivit...
Show More Location
The First Affiliated Hospital of Bengbu Medical University
Learn More & Join Trial
Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus PHASE1 This is a multi-center, open-label, phase I study....
Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
A Study of Telitacicept in Lupus Nephritis PHASE2 The purpose of this study is to evaluate the safety and efficacy of Telitac...
Show More Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Learn More & Join Trial
RC18 in Patients With Relapsing Remitting Multiple Sclerosis:a Phase II Trial PHASE2 To observe the safety and effectivity of a Recombinant Human B Lymphocyte S...
Show More Location
the Third Affiliated Hospital,Sun Yat-Sen University
Learn More & Join Trial
A Phase I Study of TACI-antibody Fusion Protein Injection (RC18) in Healthy Adult Chinese Subjects PHASE1 to evaluate the pharmacokinetics, and pharmacodynamics of a single dose of ...
Show More Learn More & Join Trial
A Study of Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy PHASE2 This is a Phase 2, multi-center, randomized, double-blind, placebo-controll...
Show More Learn More & Join Trial